order now

FDA Warns Against High-Dose Citalopram

The FDA has reduced the recommended maximum of the selective serotonin reuptake inhibitor arrhythmias and a lack of healing advantage associated with high doses. Formerly, the agency had approved a 60-mg/day dose of the antidepressant for certain patients. The new dosing instruction was prompted by post-marketing surveillance reports plus a trial linking the 60-mg dose […]

Read More